Disease: Hepatic fibrosis
- A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease
- A case of adrenal Castleman disease combined with liver cirrhosis and splenomegaly
- A novel model based on serum N-glycan markers for evaluating stage of liver necroinflammation in treatment-naive chronic hepatitis B patients
- A simple model to predict early recurrence of hepatocellular carcinoma after liver resection
- Acute Kidney Injury in Chronic Liver Disease in Northwest India: Still a Battle to Conquer
- ALKALINE PHOSPHATASE AND LIVER FIBROSIS AT DIAGNOSIS ARE ASSOCIATED WITH DEEP RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS
- Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis
- Assessment of gnostic and stereognostic functions in patients with liver cirrhosis: A comparative study with healthy controls
- Assessment of Liver Involvement in Patients With Type 2 Diabetes Mellitus in Basrah City, Iraq, Using FibroScan and Correlation With Risk Factors
- Association of serum lipid profile with liver fibrosis in HCV-coinfected HIV patients on suppressive anti-retroviral therapy
- Biomechanical Assessment of Liver Integrity: Prospective Evaluation of Mechanical Versus Acoustic MR Elastography
- Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation
- Causal effects of autoimmune diseases on thyroid cancer: a two-sample Mendelian randomization study
- Causal Effects of Smoking, Alcohol Consumption, and Coffee Intake on Hepatobiliary and Pancreatic Diseases: A Mendelian Randomization Study
- Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management
- Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
- Contemporary Awareness of Nonalcoholic Fatty Liver Disease and Viral Hepatitis Based on the Stage
- Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases
- Cryptococcus neoformans fungemia in a liver transplant patient: case report and literature review
- Cysteine sulfenylation contributes to liver fibrosis via the regulation of EphB2-mediated signaling
- Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
- Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam
- Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis
- Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis
- Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
- Eicosapentaenoic acid administration ameliorates the progression of liver fibrosis after laparoscopic Kasai portoenterostomy
- Endogenous PGD2 acting on DP2 receptor counter regulates Schistosoma mansoni infection-driven hepatic granulomatous fibrosis
- Epidemiology and risk factors for angiodysplasias of the upper and lower gastrointestinal tract: A large population-based study
- Epidemiology of Metabolic Dysfunction Associated Steatotic Liver Disease
- Establishment and Evaluation of a Noninvasive Metabolism-Related Fatty Liver Screening and Dynamic Monitoring Model: Cross-Sectional Study
- Evaluating Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure among Native Americans
- Experimental study on H(2)O(2) activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba"
- Exploring novel A<sub>2A</sub>AR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents
- Exploring the cytoprotective role of mesenchymal stem Cell-Derived exosomes in chronic liver Fibrosis: Insights into the Nrf2/Keap1/p62 signaling pathway
- Expression of Vascular Adhesion Protein-1 and Thrombospondin-1 in Gingival Crevicular Fluid of Patients with Periodontitis and Non-Alcoholic Fatty Liver Disease
- Factors associated with pre-treatment hyperferritinemia in patients with chronic hepatitis C virus infection
- Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease
- From MASLD to HCC: What's in the middle?
- FTO-mediated m (6)A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis
- GSK805 inhibits alpha-smooth muscle expression and modulates liver inflammation without impairing the well-being of mice
- Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format
- Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress
- Hepatoprotective effects of diosmin: a narrative review
- Higher In-Hospital Mortality among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure
- Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
- Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Impact of hepatic resection in the treatment of hepatocellular carcinoma
- Impacts of smoking on alcoholic liver disease: a nationwide cohort study
- Incidence of liver complications with hemochromatosis associated HFE p.C282Y homozygosity: The role of central adiposity
- Informatics driven solutions for optimal care delivery in liver transplantation
- Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia
- Intrinsic Causes of Nonfibrotic Portal Hypertension-A Clinicopathologic Review of 56 Patients
- Inverse association between lung function and nonalcoholic fatty liver disease: An observational and mendelian randomization study
- Lactucin reverses liver fibrosis by inhibiting TGF-beta1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism
- Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
- Liver Stiffness and Steatosis Measurements with iLivTouch and FibroScan: A Comparative Study
- Metabolic characteristics of patients with MetALD: Caveats of a new definition
- Metabolic Dysfunction-Associated Fatty Liver Disease and Fibrosis Status in Patients with Type 2 Diabetes Treated at Internal Medicine Clinics: Turkiye DAHUDER Awareness of Fatty Liver Disease (TR-DAFLD) Study
- MRI paraspinous skeletal muscle enhancement: A potential imaging biomarker for assessing clinical liver cirrhosis severity
- Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis
- NLRP3 inflammasome inhibition decreases Schistosomiasis japonica-induced granulomatous inflammation and fibrosis in BALB/c mice
- NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease
- Non-pharmacological Interventions for Muscle Cramps and Pain in Patients With Cirrhosis: A Systematic Review
- Novel Vibrio vulnificus sequence type 540 infection in a hepatitis patient
- Obstructive Sleep Apnea and Medical Comorbidities in the Asian Population: Evidence From a Nationwide Healthcare System Data in South Korea
- PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis
- Pediatric Combined Heart-liver Transplantation: A Single-center Long-term Experience
- PF127/bleomycin hydrogel promotes subcutaneous extracellular matrix remodeling and fibrosis to construct personalized flaps through the TGFbeta-Col signaling pathway
- PPARbeta/delta attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells
- Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists
- Prognostic factors in patients with intrahepatic cholangiocarcinoma
- Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatment
- Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
- Quadruple Complication in a Patient With Liver Cirrhosis: A Diagnostic Conundrum
- Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
- Reply to: Correspondence on "Cardiomyopathy in cirrhosis: From pathophysiology to clinical care"
- Reply to: Does encephalopathy with early onset after TIPS impact on mortality?
- Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment
- Role of multiparametric US in the preoperative assessment of hepatic parenchyma in patients with liver tumors
- Role of peripheral inflammation in minimal hepatic encephalopathy
- Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure
- Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease
- Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study
- Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery
- Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
- Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study
- Targeting the liver clock improves fibrosis by restoring TGF-beta signaling
- Temporal evolution of living donor liver transplantation survival - A UNOS registry study
- The impact of restrictive blood transfusion on the safety of patients with esophageal varices after endoscopic variceal ligation: A single-center retrospective study
- The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
- The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols
- Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-up
- Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Type 1 diabetes and combined acute and chronic complications are associated with risk of progression of liver fibrosis: a Mendelian randomization study
- Understanding acute kidney injury (AKI) in liver cirrhosis from the acute-on-chronic liver failure (ACLF) perspective
- Unveiling Endogenous Serum Peptides as Potential Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis
- US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study
- Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma